Introductory Chapter: Epigenetics in Summary by Meccariello, Rosaria
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books










In 1940 the developmental biologist Conrad H. Waddington firstly used the 
term “epigenetics” to describe “the interaction of genes with their environment, which 
bring the phenotype into being” [1]. Two years later, Conrad Waddington pointed out 
that “It is possible that an adaptive response can be fixed without waiting for the occur-
rence of a mutation” [2]. Thus, epigenetic modifications are heritable and reversible 
modifications that significantly affect gene expression without any change in the 
nucleotide sequence of DNA [3].
2. Molecular mechanisms
Classically, epigenetic mechanisms include (i) the methylation of DNA, (ii) the 
imprinting, (iii) the remodeling of chromatin, and (iv) the production of noncod-
ing RNA (ncRNA) [4, 5].
The methylation of DNA usually occurs at the 5-position of DNA cytosine 
(5mC) in the CpG islands located within the promoter region of specific genes; such 
a modification inhibits both the binding of transcription factors to DNA and affects 
the recruitment of proteins involved in chromatin remodeling [6, 7], thus causing 
gene silencing.
Genomic imprinting is a DNA methylation-dependent phenomenon, occurring 
during embryogenesis; it causes genes to be expressed from a parent of origin-
specific manner [8] and specifically interests at some genetic loci.
Nuclear DNA is structured in chromatin, an instructive DNA scaffold that can 
respond to external cues regulating DNA activity, composed of histone and nonhis-
tone proteins [9]. Euchromatin, which is the transcriptionally active region of the 
DNA, represents the loosely folded part of the chromatin; heterochromatin, which 
is a transcriptionally poorly active region of the DNA, represents the tightly folded 
part of the chromatin [10]. Therefore, the transcription rate of genes is strongly 
affected by dynamic chromatin remodeling. In this respect, posttranslational 
modifications of histone tails like methylation and acetylation play critical roles, 
by affecting either the affinity of transcriptional factors for gene promoter region 
or the recruitment to chromatin of nonhistone protein, thus disturbing chromatin 
contacts [10]. Histone tail acetylation usually promotes the transcription and is a 
feature of euchromatin; by contrast, histone tail methylation has usually an inhibi-
tory role for transcription and is a feature of heterochromatin.
The family of ncRNA includes a large set of RNAs like the well-known 
microRNA (miRNA) or the less known long noncoding RNA (lnRNA) and tRNA 
fragments (tRF) among others [11]. NcRNAs are involved in the control of gene 
expression and in the regulation of many biological functions in several tissues; 
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their expression rate is affected by environmental cues; thus, their expression rate 
changes in health and disease. Furthermore, the detection of ncRNA in biological 
fluids makes them a possible epigenetic biomarker for the prognosis, the diagnosis, 
and the treatment of diseases [12–14].
Thus, an epigenetic machinery comprising various writers, readers, and erasers 
that have unique structures, functions, and modes of action like the de novo and 
maintenance DNA methyltransferases, histone acetyltransferases, deacetylases, 
methyltransferases and demethylases, or the ncRNA biosynthetic pathways has 
been identified in living organisms [13]. However, additional epigenetic mecha-
nisms such as the delivery among tissues of epigenetic marks within extracellular 
vesicles, exosomes, or microvesicles are starting to emerge, providing evidence of 
upcoming communication pathways in which the products of specific cell types 
may affect the expression rate of specific RNAs in target tissues [15–17].
3. Epigenetics in health and disease
In mammals, epigenetic signature is firstly defined in the embryo [18, 19], but 
this mark is deeply remodeled during the life course as a direct consequence of 
environmental cues and lifestyle which includes diet, stress, pollutants, smoking, 
endocrine-disrupting chemicals, physical activity, sedentary life, etc. Therefore, 
genome activity is epigenetically modulated under exogenous influence, and the 
environment-dependent changes in gene activity stably propagate from one genera-
tion of cells to the next one. Epigenetic changes impact genome functions, thus 
affecting health and disease status and also behavior; aging-related diseases, cancer, 
immunity and related disorders, obesity, metabolic disorders, infertility, and 
cardiovascular and neurological diseases represent only few examples of environ-
mentally dependent diseases, and the literature in the field is growing up day by day 
[20–35].
Individual health or disease status strongly depends on epigenetic marks, but 
“parental experiences” may be epigenetically transmitted to the offspring, thus 
causing trans-generational epigenetic inheritance and affecting offspring health. 
Such a process requires the transmission of epigenetic marks through gametes 
and influences fertilization, embryo development, embryo gene expression, and 
phenotype [36]. Particularly interesting is the possibility that spermatozoa may use 
ncRNAs as carrier of paternal experiences, thus providing an “epigenetic memory” 
capable of affecting embryo development and health with consequences on adult 
offspring phenotype [13, 32, 33].
4. Conclusions and future perspectives
Taken together, both environment and lifestyle deeply affect DNA functions, 
and their influence may be transmitted to the next generations with consequences 
on health status. However, experimental data point out that epigenetic marks, and 
in particular circulating ncRNAs, may represent upcoming biomarkers for the 
prevention, the diagnosis, and the treatment of diseases, due to the great potential 
laying in developing epigenetic therapies [37–39].
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